webinars

WEBINAR

Counterparty Risk in the Basel III Endgame: Capital, XVA and the New Pricing Discipline

Sep 17, 2026

This session will assess the real capital impact of SA‑CCR, the expanding role of XVA and collateral optimisation in pricing and balance‑sheet management, and the integration of risk, capital and trading analytics across jurisdictions — concluding with a forward‑looking assessment of supervisory priorities, capital efficiency pressures and the structural shifts institutions should prepare for over the next 12–18 months.

WEBINAR

The Completeness Challenge: Architecting Surveillance for New Frontiers and 24/7 Markets

Aug 6, 2026

This webinar will bring together industry experts to discuss the practical challenges and strategies for building an effective surveillance framework. The panellists will discuss what works in practice, from tackling data governance issues to harnessing the potential of AI and preparing for the operational realities of tomorrow's markets. 

Hosted by Regulation Asia and NICE Actimize

WEBINAR

Measuring What Matters: Harm, Metrics and the Future of AML Effectiveness in Asia-Pacific

Jun 17, 2026

This webinar will go beyond traditional metrics to critically examine whether current frameworks capture real-world impact. We will explore how ‘harm’ can be better defined and measured, and how AI and advanced analytics can provide a more meaningful assessment of structural disruption, moving the industry from measuring activity to verifying impact.

Hosted by Regulation Asia and NICE Actimize

WEBINAR

Beyond the Headlines: What APAC’s AML Enforcement Is Signalling

May 28, 2026

This session will examine what recent AML enforcement actions across Asia are signalling about the direction of supervision. Drawing on cases from key financial centres, it will explore how institutions are being assessed on the effectiveness of their customer risk management, from data integrity and risk assessment design to refresh cycles and governance accountability.

Hosted by Regulation Asia and Fenergo